Manapad, Alhadz A.
HRN: 23-76-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/28/2023
11/04/2023
IVT
42mg
Q24
Thickly MSAF; PSNB
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes